nach oben

Erschienen in:

08.09.2018 | Gynecologic Oncology

Seroma in breast surgery: all the surgeons fault?

verfasst von: Florian Ebner, Thomas W. P. Friedl, Amelie de Gregorio, Krisztian Lato, Inga Bekes, Wolfgang Janni, Nikolaus de Gregorio

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Despite a trend for less radical surgical approaches in breast cancer due to better understanding of tumour biology and new treatment options such as neoadjuvant chemotherapy (NAC) and intra-operative radiotherapy (IORT), seroma production remains one of the main surgical side effects that can result in prolonged recovery, delay of radiotherapy and patient discomfort. The aim of this study is to provide an update on risk factors for seroma production after breast cancer surgery considering the latest treatment options.

Methods

A retrospective analysis of seroma production in primary breast cancer patients treated between 01.01.2010 and 31.12.2014 at the Breast Cancer Centre, University Hospital Ulm, was performed. Patients with previous breast/axillary surgery or more than one intervention were excluded. Seroma formation was measured using wound drains placed in breast and axilla.

Results

In total, 581 patients met the inclusion criteria. Median age at diagnosis was 60 years, and median BMI 25.6 kg/m². 60 (10.3%) patients had a mastectomy, 175 (30.1%) patients received IORT, and 72 (12.4%) patients received NAC. Median amount of seroma production was 82.5 ml (range 0–3012.5 ml). Multivariate analysis revealed that most of the observed variation in seroma production was due to type of surgery (mastectomy vs. breast conserving), length of surgery and number of removed lymph nodes. Both NAC and IORT explained a significant but very small amount of the observed variation in seroma production.

Conclusion

The most important factors for seroma production are extent and duration of breast surgery.

Veronesi U, Luini A, Galimberti V, Zurrida S (1991) Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute trials. World J Surg 18(1):70–75CrossRef

Abt NB, Flores JM, Baltodano PA, Sarhane KA, Abreu FM, Cooney CM et al (2014) Neoadjuvant chemotherapy and short-term morbidity in patients undergoing mastectomy with and without breast reconstruction. JAMA Surg 149(10):1068–1076CrossRefPubMedCentralPubMed

Sedlmayer F, Sautter-Bihl M-L, Budach W, Dunst J, Fastner G, Feyer P et al (2013) DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Strahlenther Onkol 189(10):825–833CrossRefPubMedCentralPubMed

Boostrom SY, Throckmorton AD, Boughey JC, Holifield AC, Zakaria S, Hoskin TL et al (2009) Incidence of clinically significant seroma after breast and axillary surgery. J Am Coll Surg 208(1):148–150CrossRefPubMed

Silverstein MJ, Fastner G, Maluta S, Reitsamer R, Goer DA, Vicini F et al (2014) Intraoperative radiation therapy: a critical analysis of the ELIOT and TARGIT trials. Part 2–TARGIT. Ann Surg Oncol 21(12):3793–3799CrossRefPubMedCentralPubMed

Buchholz TA, Somerfield MR, Griggs JJ, El-Eid S, Hammond MEH, Lyman GH et al (2014) Margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer: American Society of Clinical Oncology endorsement of the Society of Surgical Oncology/American Society for Radiation Oncology consensus guideline. J Clin Oncol 32(14):1502–1506CrossRefPubMed

Kreienberg R, Kopp I, Albert U-S, Bartsch HH, Beckmann MW, Berg D et al (2012) Interdisziplinäre S3-Leitlinie und Nachsorge des Leitlinie. Ger Cancer Soc 2012(7):32–45

Srivastava V, Basu S, Shukla VK (2012) Seroma formation after breast cancer surgery: what we have learned in the last two decades. J Breast Cancer 15(4):373–380CrossRefPubMedCentralPubMed

Kuroi K, Shimozuma K, Taguchi T, Imai H, Yamashiro H, Ohsumi S et al (2006) Evidence-based risk factors for seroma formation in breast surgery. Jpn J Clin Oncol 36(4):197–206CrossRefPubMed

10.

Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP et al (2005) Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23(19):4312–4321CrossRefPubMed

11.

Ebner FK, Friedl TWP, Reich A, Janni W, Rempen A, Degregorio N et al (2013) Does non-placement of a drain in breast surgery increase the rate of complications and revisions? Geburtshilfe Frauenheilkd 73(11):1128–1134CrossRefPubMedCentralPubMed

12.

Garbay J-R, Thoury A, Moinon E, Cavalcanti A, Di Palma M, Karsenti G et al (2012) Axillary padding without drainage after axillary lymphadenectomy—a prospective study of 299 patients with early breast cancer. Breast Care (Basel) 7(3):231–235CrossRef

13.

Taylor JC, Rai S, Hoar F, Brown H, Vishwanath L (2013) Breast cancer surgery without suction drainage: the impact of adopting a “no drains” policy on symptomatic seroma formation rates. Eur J Surg Oncol 39:334–338CrossRefPubMed

14.

Thomson DR, Sadideen H, Furniss D (2013) Drainage tube placement after lymph gland removal from the armpit for breast cancer. Wiley, New York

15.

Glechner A, Wöckel A, Gartlehner G, Thaler K, Strobelberger M, Griebler U et al (2013) Sentinel lymph node dissection only versus complete axillary lymph node dissection in early invasive breast cancer: a systematic review and meta-analysis. Eur J Cancer 49:812–825CrossRefPubMed

16.

Joyce DP, Manning A, Carter M, Hill ADK, Kell MR, Barry M (2015) Meta-analysis to determine the clinical impact of axillary lymph node dissection in the treatment of invasive breast cancer. Breast Cancer Res Treat 153:235–240CrossRefPubMed

17.

Shah-Khan M, Boughey JC (2012) Evolution of axillary nodal staging in breast cancer: clinical implications of the ACOSOG Z0011 trial. Cancer Control 19(4):267–276CrossRefPubMed

18.

Janni W, Kühn T, Schwentner L, Kreienberg R, Fehm T, Wöckel A (2014) Sentinel node biopsy and axillary dissection in breast cancer: the evidence and its limits. Dtsch Arztebl Int 111(14):244–249PubMedPubMedCentral

19.

Ebner F, Wöckel A, Janni W, Kreienberg R, Schwentner L, Wischnewsky M (2017) Personalized axillary dissection: the number of excised lymph nodes of nodal-positive breast cancer patients has no significant impact on relapse-free and overall survival. J Cancer Res Clin Oncol 143:1823–1831CrossRefPubMed

20.

Balakrishnan A, Ravichandran D (2011) Early operable breast cancer in elderly women treated with an aromatase inhibitor letrozole as sole therapy. Br J Cancer 105(12):1825–1829CrossRefPubMedCentralPubMed

21.

Hille U, Soergel P, Länger F, Schippert C, Makowski L, Hillemanns P (2002) Aromatase inhibitors as solely treatment in postmenopausal breast cancer patients. Breast J 18(2):145–150CrossRef

22.

Hind D, Wyld L, Reed MW (2007) Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review. Br J Cancer 96(7):1025–1029CrossRefPubMedCentralPubMed

23.

Headon H, Wazir U, Kasem A, Mokbel K (2016) Surgical treatment of the primary tumour improves the overall survival in patients with metastatic breast cancer: a systematic review and meta-analysis. Mol Clin Oncol 4(5):863–867CrossRefPubMedCentralPubMed

24.

Cortadellas T, Córdoba O, Espinosa-Bravo M, Mendoza-Santin C, Rodríguez-Fernández J, Esgueva A et al (2011) Electrothermal bipolar vessel sealing system in axillary dissection: a prospective randomized clinical study. Int J Surg 9(8):636–640CrossRefPubMed

25.

Manouras A, Markogiannakis H, Genetzakis M, Filippakis GM, Lagoudianakis EE, Kafiri G et al (2008) Modified radical mastectomy with axillary dissection using the electrothermal bipolar vessel sealing system. Arch Surg. 143(6):575–580 (discussion 581) CrossRefPubMed

26.

Nespoli L, Antolini L, Stucchi C, Nespoli A, Valsecchi MG, Gianotti L (2012) Axillary lymphadenectomy for breast cancer. A randomized controlled trial comparing a bipolar vessel sealing system to the conventional technique. Breast 21(6):739–745CrossRefPubMed

27.

Canavese G, Catturich A, Vecchio C, Gipponi M, Tomei D, Sertoli MR et al (1997) Surgical complications related to peri-operative adjuvant chemotherapy in breast cancer. Results of a prospective, controlled, randomized clinical trial. Eur J Surg Oncol 23(1):10–12CrossRefPubMed

28.

Kraus-Tiefenbacher U, Welzel G, Brade J, Hermann B, Siebenlist K, Wasser KS et al (2010) Postoperative seroma formation after intraoperative radiotherapy using low-kilovoltage X-rays given during breast-conserving surgery. Int J Radiat Oncol Biol Phys 77(4):1140–1145CrossRefPubMed

29.

Tuschy B, Berlit S, Romero S, Sperk E, Wenz F, Kehl S et al (2013) Clinical aspects of intraoperative radiotherapy in early breast cancer: short-term complications after IORT in women treated with low energy X-rays. Radiat Oncol 8:95CrossRefPubMedCentralPubMed

30.

Ebner F, Schramm A, Bottke D, Friedl TW, Wiegel T, Fink V et al (2016) Comparison of seroma production in breast conserving surgery with or without intraoperative radiotherapy as tumour bed boost. Arch Gynecol Obstet 294:861–866CrossRefPubMed

31.

Cracco S, Semprini G, Cattin F, Gregoraci G, Zeppieri M, Isola M et al (2015) Impact of intraoperative radiotherapy on cosmetic outcome and complications after oncoplastic breast surgery. Breast J 21(3):285–290CrossRefPubMed

Titel: Seroma in breast surgery: all the surgeons fault?
verfasst von: Florian Ebner
Thomas W. P. Friedl
Amelie de Gregorio
Krisztian Lato
Inga Bekes
Wolfgang Janni
Nikolaus de Gregorio
Publikationsdatum: 08.09.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 5/2018
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-018-4880-8

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Seroma in breast surgery: all the surgeons fault?

Abstract

Background

Methods

Results

Conclusion

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2018

A prospective cohort study on the prediction of the diagnosis-to-delivery time in preeclamptic pregnancies: should the sFlt-1/PlGF ratio be added to routine evaluations?

Secondary cytoreduction in ovarian cancer: who really benefits?

Acute genital ulcers: keep Lipschütz ulcer in mind

Hemodynamic effects of intramyometrial epinephrine injection for blood loss reduction in laparoscopic myomectomy

Preventative effect of celecoxib in dimethylbenz[a]anthracene-induced ovarian cancer in rats

Therapeutic role of granulocyte colony-stimulating factor (G-CSF) for infertile women under in vitro fertilization and embryo transfer (IVF-ET) treatment: a meta-analysis

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie